Literature DB >> 14747913

[Growth and differentiation factor 5 (GDF-5) composite improves the healing of necrosis of the femoral head in a sheep model. Analysis of an animal model].

H-G Simank1, F Herold, M Schneider, U Maedler, R Ries, C Sergi.   

Abstract

MATERIALS AND METHODS: After creation of necrosis in 23 sheep, the composites were implanted in half of the animals. The animals were sacrificed 6 and 12 weeks after implantation and the femora were harvested. The specimens were investigated by microradiography, computed tomography, and histologically.
RESULTS: The GDF-5 composites were effective in the necrosis model. Osseous regeneration of the necrosis and the drill track were accelerated and enhanced by the composites. In treated animals the necrosis was nearly healed and the drill track was filled with bone after 12 weeks. In the control group the track was partially filled with fibrous tissue and necrotic lesions were still present. Specific side effects of the growth factor or the matrix were not documented. This was documented by histological scoring and CT investigation. DISCUSSION: The application of an absorbable GDF-5 composite in combination with a core decompression procedure may enhance the healing of devitalized bone defects and is a promising approach for further studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747913     DOI: 10.1007/s00132-003-0541-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  25 in total

1.  Long-term healing of bone using recombinant human bone morphogenetic protein 2.

Authors:  C A Kirker-Head; T N Gerhart; S H Schelling; G E Hennig; E Wang; M E Holtrop
Journal:  Clin Orthop Relat Res       Date:  1995-09       Impact factor: 4.176

2.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

Review 3.  Non-traumatic avascular necrosis of the femoral head.

Authors:  M A Mont; D S Hungerford
Journal:  J Bone Joint Surg Am       Date:  1995-03       Impact factor: 5.284

4.  Growth/differentiation factor-5 induces angiogenesis in vivo.

Authors:  H Yamashita; A Shimizu; M Kato; H Nishitoh; H Ichijo; A Hanyu; I Morita; M Kimura; F Makishima; K Miyazono
Journal:  Exp Cell Res       Date:  1997-08-25       Impact factor: 3.905

Review 5.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

6.  Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein.

Authors:  T N Gerhart; C A Kirker-Head; M J Kriz; M E Holtrop; G E Hennig; J Hipp; S H Schelling; E Wang
Journal:  Clin Orthop Relat Res       Date:  1993-08       Impact factor: 4.176

Review 7.  [The non-traumatic femur head necrosis in the adult. I: pathophysiology, clinical picture and therapeutic options].

Authors:  S Hofmann; J Kramer; K Leder; H Plenk; A Engel
Journal:  Radiologe       Date:  1994-01       Impact factor: 0.635

8.  Long-term results of core decompression for ischaemic necrosis of the femoral head.

Authors:  A C Fairbank; D Bhatia; R H Jinnah; D S Hungerford
Journal:  J Bone Joint Surg Br       Date:  1995-01

9.  Osteonecrosis of the femoral head. Hip salvaging with implantation of a vascularized fibular graft.

Authors:  K N Malizos; P N Soucacos; A E Beris
Journal:  Clin Orthop Relat Res       Date:  1995-05       Impact factor: 4.176

Review 10.  Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors.

Authors:  M A Mont; L C Jones; T A Einhorn; D S Hungerford; A H Reddi
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

View more
  3 in total

1.  [Collagen hydroxyapatite (Healos) saturated with gentamicin or levofloxacin. In vitro antimicrobial effectiveness - a pilot study].

Authors:  C H Fürstenberg; B Wiedenhöfer; C Putz; I Burckhardt; S Gantz; K Kleinschmidt; K Schröder
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

Review 2.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

Review 3.  Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

Authors:  Lars Rackwitz; Lars Eden; Stephan Reppenhagen; Johannes C Reichert; Franz Jakob; Heike Walles; Oliver Pullig; Rocky S Tuan; Maximilian Rudert; Ulrich Nöth
Journal:  Stem Cell Res Ther       Date:  2012-02-22       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.